Professional Documents
Culture Documents
Patho Midterms
Patho Midterms
MONOCYTES
• LARGEST
• Called macrophages when they enter the tissues.
• chronic inflammation
•Immune response by activating lymphocytes and by presenting antigen to
T cells.
THROMBOCYTES
•Aka ______
• cell fragments of large megakaryocytes that are derived from the myeloid
stem cell.
•Thrombocytes have a membrane but no nucleus, cannot replicate
HEMATOPOIESIS
BLOOD CELLS
• originate in the bone marrow
• not all true cells
• Erythrocytes have no nuclei or organelles
• Platelets are just cell fragments
ERYTHROCYTES
• Most numerous of the formed elements
• average diameter of 7.8 μm
• thickness of approximately 2.5 μm.
• RBCs have a large surface area
• Can easily deform into just about any shape to move through the small BLOOD COUNT
capillaries
• Contain the oxygen-carrying protein
• For transport of oxygen
LEUKOCYTES
• 10 to 12 μm in diameter, thus much larger than RBCs.
• Constitute only 1% of the total blood volume
• responsible for the immune response
• identify and destroy cancer cells.
• participate in the inflammatory response and wound healing.
• Granulocytes/agranulocytes
NEUTROPHILS
• constitute 55% to 65% of the total white blood cells
• nuclei that are divided into three to five lobes, they are called ____
DISORDERS OF HEMOSTASIS HEMOSTASIS
Hemostasis
• Hemostasis is divided into three stages:
• 1. Vascular constriction
• 2. Formation of the platelet plug
• 3. Blood coagulation
VASCULAR CONSTRICTION
HYPERCOAGULABILITY STATES
•Increased Platelet Function
•Increased Clotting Activity
BLOOD COAGULATION
HYPERCOAGULABILITY ASSOCIATED WITH
INCREASED PLATELET FUNCTION
•Thrombocytosis : platelet count above 1,000,000/μL.
• platelet adhesion
•formation of platelet clots
• disruption of blood flow
BLEEDING DISORDERS
• Platelet disorders
• Coagulation factor deficiencies
PLATELET DISORDERS
• decreased production
• increased destruction,
• impaired function of platelets
• Thrombocytopenia HEMOGLOBIN
• decrease in platelet production
• increased sequestration of platelets in the spleen
• decreased platelet survival
LABORATORY TESTS
HEMOLYTIC ANEMIAS
HYPOPROLIFERATIVE ANEMIAS
AUTOIMMUNE NEUTROPENIA
• Primary: Mild to moderate infections for children.
• Self-limiting
•Treatment: use of antimicrobial agents
• Secondary immune-associated neutropenia: rheumatoid arthritis (RA)
and systemic lupus erythematosus (SLE)
MEGALOBLASTIC ANEMIA • Felty syndrome: a triad of splenomegaly, recurrent pulmonary infections,
and neutropenia.
THE THALASSEMIAS
INFECTION-RELATED NEUTROPENIA
• viral, bacterial, and parasitic, may cause neutropenia
•the most common : viral
• decreased neutrophil production
•loss of neutrophils by toxins
• problems resulting in neutrophil sequestration in the spleen.
DRUG-RELATED NEUTROPENIA
• antipsychotic drug : clozapine, have been shown to cause accelerated
apoptosis of neutrophils — agranulocytosis
• Other drugs, such as the β-lactam antibiotics (e.g., cephalosporins)
• anticonvulsant drugs (e.g., carbamazepine) may inhibit the
colony-forming units of granulocytes
• reversible on discontinuation of the drug.
CARDIOVASCULAR FUNCTION HEART SOUNDS
IMPORTANT PRINCIPLES
BLOOD PRESSURE (BP)
BP = CO x TPR
= (HR x SV) X TPR
*Cardiac output: volume of blood being pumped by the heart per minute
*Stroke volume: volume of blood pumped with each heart beat (N:
55-100mL)
At rest: 5L/min
Max CO (Non-Athlete): 20L/min
Max CO (Athlete): 30L/min
Pulse Pressure
PP = SBP - DBP
THE HEART
Pericardium
Myocardium
Endocardium
Fibrous skeleton
Interatrial & Interventricular septa
Atrium
Ventricle
Pericardial cavity
Myocardium Venous Thrombosis
Endocardium Virchow’s Triad: (risk factors)
Fibrous skeleton Stasis of blood
Interatrial & Interventricular septa Hypercoagulability
Atrium Vessel wall injury
Ventricle
*note: inflammation if a sign and not a risk factor
TRACHEA
• In the trachea, C-shaped cartilages are found anteriorly LUNG VOLUMES AND CAPACITIES
• Right bronchi is wider, shorter and more vertical (hence it is more prone NOTE: “These are the only 3 areas in the respiratory system capable of gas
to aspiration of material) exchange. Be careful with terminal bronchiole vs. respiratory bronchiole –
respiratory bronchiole is the first part of the respiratory unit of the lung
• Trachea → Main Stem Bronchi → Lobar Bronchi → Segmental Bronchi capable of gas exchange. Not terminal bronchiole.”
→→→ Terminal bronchioles → Respiratory bronchiole → Alveoli
COMMON COLD
BRONCHIOLE • Most common causative agent: Rhinoviruses
• Respiratory Bronchiole is capable of Gas Exchange • Others: Parainfluenza viruses, Respiratory syncytial virus RSV,
• (+) presence of Respiratory Epithelium Coronaviruses
• GOBLET CELLS: Produces Mucus; Hyperplasia, Hypertrophy seen in • Most commonly affected are SCHOOL CHILDREN
chronic smokers • Most common source of spread: FINGERS (poor hand hygiene)
• CLARA CELLS (CLUB CELLS): Metabolize air-borne toxins • Most common portals of entry: Nasal mucosa, Conjunctiva
• DUST CELLS (ALVEOLAR MACROPHAGES): Blood element that • Highly contagious on the first 3 days after onset of symptoms
removes particles trapped in the alveoli • Incubation Period: 5 days
• Self-limiting: 5-6 days
LUNGS • Complication: Acute Otitis Media (40-75% of cases in children)
• Weighs 1kg • Antibiotics are ineffective in common cold
• 60% lung tissue
• 40% blood
• RIGHT LUNG RHINOSINUSITIS
• 3 Lobes (Upper, Middle, Lower) • Inflammation of nasal passages and paranasal sinuses
• Oblique Fissure, Horizontal Fissure • Mucosal swelling from either allergic rhinitis/acute upper respiratory
• LEFT LUNG tract infection causing obstruction to the ostia that impairs mucociliary
• 2 Lobes (Upper, Lower) clearance mechanism—no drainage system
• Oblique Fissure • (+) facial pain/tenderness
• PLEURAL FLUID • Resolves 5-7 days without treatment NLE-relevant fact: “Handwashing is
• Found in potential space between the two pleura the single, most effective method to prevent the spread of communicable
• Keeps the 2 pleura together (allows them to slide) diseases.”
ALVEOLI INFLUENZA
• TYPE I PNEUMOCYTE • Rapid onset of profound malaise
• 96-98% of surface area • Complication: Viral pneumonia > Hypoxemia > Survivor with diffused
• thin, flat, does NOT secrete surfactant pulmonary fibrosis or Death
• For Gas Exchange • Spread via inhalation of droplet nuclei
• TYPE II PNEUMOCYTE
• 2-4% of surface area COMMUNITY-ACQUIRED PNEUMONIA
• Small, cuboidal, found at corners of alveoli • Most common causative agent: Streptococcus pneumoniae
• For Surfactant production • 2 types:
• Decreases surface tension (preventing alveolar collapse) • Bacterial: Neutrophilic infiltrates; intraalveolar inflammation
• Viral: Mononuclear infiltrates (lymphocytes, macrophages); interstitial
KEY POINTS: LUNG SURFACTANT inflammation
• LUNG SURFACTANT: Helps prevent alveolar collapse; Decreased in the
lungs of chronic smokers
Pulmonary Tuberculosis Acute Respiratory Distress Syndrome
• *insert book NTP 2020* • Failure in gas exchange due to either heart/lung failure or both
• Caused by Mycobacterium tuberculosis infection • *not a specific disease—occurs due to numbers of conditions that impair
• Droplet nuclei—aerosolized by coughing, sneezing, speaking ventilation
• Caseation necrosis & cavitation (Typical TB lesion) • Mismatching of ventilation-perfusion: occurs when areas of lung are
• Clinical manifestation: Fever, chills, cough for more than 2 weeks, night ventilated but not perfused/perfused but not ventilated
sweats, hemoptysis • Ventilation (V): movement of air in and out of airways (aka Breathing)
• Bacteriologically confirmed: Smear/culture/Xpert MTB/RIF (+) • Perfusion (Q): exchange of O2 or CO2
• Clinically diagnosed: AFB (-) but radiologic evidence is consistent with
PTB
Pulmonary Tuberculosis
• Mantoux test – PPD
• >/= 5 : positive for HIV patients
• >/=10 : positive for healthy individuals
• *treatment*
Pleural Effusion
• (Normal) Pleural fluid: 15 mL – serous, acellular, clear fluid
• PE: excess fluid in pleural cavity
• Congestive heart failure: increased capillary hydrostatic pressure
• Pneumonia: Increased capillary permeability
• Nephrotic syndrome: decreased capillary oncotic pressure
Pneumothorax
• Presence of air in the pleural caivity
• Assocated in Emphysema, asthma, PTB (airspaces may rupture)
Bronchial Asthma
• *GINA guidelines*
• Chronic change: Airway remodeling
• X-ray: Hyperaerated lungs (due to air trapping)
• Strongest risk factor: Genetic predisposition—development of
IgEmediated response to common allergens
• Environmental triggers: Tobacco smoke/pollution, dust mites, GERD,
AURI, exercise
• Exaggerated hyperresponsiveness to a variety of stimuli
• Clinical manifestations: Wheezing, breathlessness, chest tightness, cough
worse at night and early in the morning
• Reversible clinical manifestations, (compared to COPD that is
IRREVERSIBLE)
• Use of Inhaled corticosteroids: risk for oral candidiasis/oral thrush;
encourage proper oral hygiene after use of ICS
Emphysema
• Increased (Antero-posterior) AP chest diameter “Barrel chest”
• Patho: Airway destruction and loss of elastic recoil (air trapping)
• Morphology: Large alveoli
• Types:
• Panacinar – a1 antitrypsin protein deficiency
• Centriacinar – Cigarette smoking
Chronic bronchitis
• Increased secretions
• Chronic productive cough
• Patho: Airway inflammation “-itis”
• Chronic inflammation + mucus gland hypertrophy leads to fibrosis